🏛️ Verified NIH Record • Updated 2025-09-29
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) (NCT05531526)
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 Over 52 Weeks in Participants With Early Alzheimer's Disease (Polaris-AD)
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: AriBio Co., Ltd.
🩺 Plain-English Summary (8th-Grade Level)
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to evaluate the efficacy and safety of AR1001 for the treatment of participants with early AD.
Who can join: Review the eligibility criteria below.
Location: IMA Clinical Research Phoenix — Phoenix, Arizona
Age range: 55 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (198 Sites)
Showing the first 25 of 198 sites.
- IMA Clinical Research Phoenix — Phoenix, Arizona
- Perseverance Research Center, LLC — Scottsdale, Arizona
- Clinical Endpoints - N. Scottsdale — Scottsdale, Arizona
- Banner Sun Health Research Institute — Sun City, Arizona
- Voyage Medical — Tempe, Arizona
- Sutter Health's Palo Alto Medical Foundation — Burlingame, California
- Neuro-Pain Medical Center — Fresno, California
- Fullerton Neurology and Headache Center — Fullerton, California
- Esperanza Clinical — Murrieta, California
- Valley Clinical Trials, INC — Northridge, California
- Havana Research Institute — Pasadena, California
- Kaizen Brain Center — San Diego, California
- Adaptive Research — San Jose, California
- The Neuron Clinic — San Marcos, California
- Stanford Neuroscience Health Center — Stanford, California
- Denver Neurological Research — Denver, Colorado
- Mile High Research Center — Denver, Colorado
- CenExel Rocky Mountain Clinical Research — Englewood, Colorado
- Topaz Clinical Research — Apopka, Florida
- BayCare Health System, Inc — Clearwater, Florida
- Vertex Research Group — Clermont, Florida
- Arrow Clinical Trial — Daytona Beach, Florida
- Brainstorm Research - Loxahatchee — Loxahatchee Groves, Florida
- ClinCloud LLC — Maitland, Florida
- Verus Clinical Research, Corp — Miami, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer Disease
- The Use of Memantine for Prevention of Alzheimer's Disease — Charlottesville, Virginia
- Investigation of Inflammation Using [C-11]-CS1P1 — St Louis, Missouri
- Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia — Palo Alto, California
- A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) — Gilbert, Arizona
- High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease — Cambridge, Massachusetts
- A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Phoenix, Arizona
Explore by condition: All Alzheimer Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.